Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Hendlisz

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
Current Opinion in Oncology|June 4, 2005
Molecular medicine: are we, clinicians, becoming old-fashioned?Alain Hendlisz
Current Opinion in Oncology|June 8, 2015
Of art and science: is personalized medicine getting personal enough?Alain Hendlisz
Current Opinion in Oncology|May 19, 2017
The meaningness of colon cancer sidednessAlain Hendlisz
Current Opinion in Oncology|June 4, 2026
5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug developmentAlain Hendlisz
Current Opinion in Oncology|June 5, 2007
Don't believe ... check!!Alain Hendlisz
Current Opinion in Oncology|April 6, 2012
The confusion around neuroendocrine tumorsAlain Hendlisz, Amélie Deleporte
Current Opinion in Oncology|June 17, 2020
Editorial: Adjuvant chemotherapy for gastrointestinal cancers: we can do much betterFrancesco Sclafani, Alain Hendlisz
Current Opinion in Oncology|May 4, 2016
Too little benefit for too much toxicity: rethinking the adjuvant development model in colon cancerAlain Hendlisz, Harry Bleiberg
Current Opinion in Oncology|June 4, 2026
Pain management in pancreatic cancer: time to change our strategy!Daniel Blero, Alain Hendlisz
Current Opinion in Oncology|May 16, 2009
Adjuvant trials design in colon cancerAlain Hendlisz, Vassilis Golfinopoulos
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
Current Opinion in Oncology|June 4, 2005
Molecular medicine: are we, clinicians, becoming old-fashioned?Alain Hendlisz
Current Opinion in Oncology|June 8, 2015
Of art and science: is personalized medicine getting personal enough?Alain Hendlisz
Current Opinion in Oncology|May 19, 2017
The meaningness of colon cancer sidednessAlain Hendlisz
Current Opinion in Oncology|June 4, 2026
5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug developmentAlain Hendlisz
Current Opinion in Oncology|June 5, 2007
Don't believe ... check!!Alain Hendlisz
Current Opinion in Oncology|April 6, 2012
The confusion around neuroendocrine tumorsAlain Hendlisz, Amélie Deleporte
Current Opinion in Oncology|June 17, 2020
Editorial: Adjuvant chemotherapy for gastrointestinal cancers: we can do much betterFrancesco Sclafani, Alain Hendlisz
Current Opinion in Oncology|May 4, 2016
Too little benefit for too much toxicity: rethinking the adjuvant development model in colon cancerAlain Hendlisz, Harry Bleiberg
Current Opinion in Oncology|June 4, 2026
Pain management in pancreatic cancer: time to change our strategy!Daniel Blero, Alain Hendlisz
Current Opinion in Oncology|May 16, 2009
Adjuvant trials design in colon cancerAlain Hendlisz, Vassilis Golfinopoulos
Pageof 14